eMedicine Specialties > Gastroenterology > Biliary

Cholelithiasis: Differential Diagnoses & Workup

Author: Douglas M Heuman, MD, FACP, FACG, AGAF, Chief of Hepatology, Hunter Holmes McGuire Department of Veterans Affairs Medical Center; Professor, Department of Internal Medicine, Division of Gastroenterology, Virginia Commonwealth University School of Medicine
Coauthor(s): Anastasios A Mihas, MD, DMSc, FACP, FACG, Professor, Department of Medicine, Division of Gastroenterology, Virginia Commonwealth University School of Medicine; Consulting Staff, Virginia Commonwealth University Hospitals and Clinics; Chief of GI Clinical Research, Director of GI Outpatient Service, Associate Director of Hepatology, Hunter Holmes McGuire Veterans Affairs Medical Center; Jeff Allen, MD, Assistant Professor, Department of Surgery, University of Louisville
Contributor Information and Disclosures

Updated: Aug 25, 2009

Differential Diagnoses

Appendicitis
Gastric Volvulus
Cholangiocarcinoma
Gastritis, Acute
Cholangitis
Gastritis, Chronic
Cholecystitis
Gastroesophageal Reflux Disease
Gallbladder Cancer
Pancreatic Cancer
Gallbladder Mucocele
Pancreatitis, Acute
Gallbladder Tumors
Pancreatitis, Chronic
Gastric Ulcers
Peptic Ulcer Disease

Other Problems to Be Considered

Gallbladder gangrene

Workup

Laboratory Studies

  • Patients with uncomplicated cholelithiasis or simple biliary colic typically have normal laboratory test results.
  • Acute cholecystitis is associated with polymorphonuclear leukocytosis. In severe cases, mild elevations of liver enzymes may be caused by inflammatory injury of the adjacent liver.
  • Choledocholithiasis with acute common bile duct obstruction initially produces an acute increase in the level of liver transaminases (alanine and aspartate aminotransferases), followed within hours by a rising serum bilirubin level. If obstruction persists, a progressive decline in the level of transaminases with rising alkaline phosphatase and bilirubin levels may be noted over several days. Concurrent obstruction of the pancreatic duct by a stone in the ampulla of Vater may be accompanied by increases in circulating lipase and amylase levels.
    • In patients with suspected gallstone complications, blood tests should include a complete blood cell (CBC) count with differential, liver function panel, and amylase and lipase.
    • Repeated testing over hours to days may be useful in evaluating patients with gallstone complications. Improvement of the levels of bilirubin and liver enzymes may indicate spontaneous passage of an obstructing stone. Conversely, rising levels of bilirubin and transaminases with progression of leukocytosis in the face of antibiotic therapy may indicate ascending cholangitis with need for urgent intervention.

Imaging Studies

  • Upright and supine abdominal radiographs are occasionally helpful in establishing a diagnosis of gallstone disease.
    • Black pigment or mixed gallstones may contain sufficient calcium to appear radiopaque on plain x-ray films. The finding of air in the bile ducts on plain x-ray films may indicate development of a choledochoenteric fistula or ascending cholangitis with gas-forming organisms. Calcification in the gallbladder wall (the so called porcelain gallbladder) is indicative of severe chronic cholecystitis.
    • The main role of plain x-ray films in evaluating patients with suspected gallstone disease is to exclude other causes of acute abdominal pain, such as intestinal obstruction, visceral perforation, renal stones, or chronic calcific pancreatitis.
  • Ultrasonography is the most sensitive, specific, noninvasive, and inexpensive test for the detection of gallstones.
    • Gallstones appear as echogenic foci in the gallbladder. They move freely with positional changes and cast an acoustic shadow.
    • In acute cholecystitis, ultrasonography may demonstrate edema of the gallbladder wall and pericholecystic fluid. Ultrasonography is also helpful in cases of suspected acute cholecystitis to exclude hepatic abscesses and other liver parenchymal processes.
    • Routine ultrasonography is less effective for diagnosing stones in the common bile duct, because the distal bile duct passes behind the duodenum and is hidden from view by intestinal gas. Dilatation of the common bile duct on ultrasonographic images is an indirect indicator of bile duct obstruction but may be absent if the obstruction is of recent onset.
  • Computed tomography (CT) scanning is more expensive and less sensitive than ultrasonography for the detection of gallbladder stones. CT scanning is often used in the workup of abdominal pain, as it provides excellent images of all the abdominal viscera. CT scanning is superior to ultrasonography for the demonstration of gallstones in the distal common bile duct.
  • Magnetic resonance imaging (MRI) with magnetic resonance cholangiopancreatography (MRCP) has emerged as an excellent imaging study for noninvasive identification of gallstones anywhere in the biliary tract, including the common bile duct (see Image 2 or below). Because of its cost and the need for sophisticated equipment and software, it is usually reserved for cases in which choledocholithiasis is suspected.
    Magnetic resonance cholangiopancreatography (MRCP...

    Magnetic resonance cholangiopancreatography (MRCP) showing 5 gallstones in the common bile duct (arrows). In this image, bile in the duct appears white; stones appear as dark-filling defects. Similar images can be obtained by taking plain radiographs after injection of radiocontrast material in the common bile duct, either endoscopically (endoscopic retrograde cholangiography) or percutaneously under fluoroscopic guidance (percutaneous transhepatic cholangiography), but these approaches are more invasive.

    Magnetic resonance cholangiopancreatography (MRCP...

    Magnetic resonance cholangiopancreatography (MRCP) showing 5 gallstones in the common bile duct (arrows). In this image, bile in the duct appears white; stones appear as dark-filling defects. Similar images can be obtained by taking plain radiographs after injection of radiocontrast material in the common bile duct, either endoscopically (endoscopic retrograde cholangiography) or percutaneously under fluoroscopic guidance (percutaneous transhepatic cholangiography), but these approaches are more invasive.

  • Technetium-99m (99m Tc) hepatoiminodiacetic acid (HIDA) scintigraphy is occasionally useful in the differential diagnosis of acute abdominal pain. HIDA is normally taken up by the liver and excreted into bile, where it fills the gallbladder and can be detected with a gamma camera. Failure of HIDA to fill the gallbladder, while flowing freely into the duodenum, is indicative of cystic duct obstruction. A nonvisualizing gallbladder on a HIDA scan in a patient with abdominal pain supports a diagnosis of acute cholecystitis.
  • Endoscopic retrograde cholangiopancreatography (ERCP) permits x-ray imaging of the bile ducts. In this procedure, an endoscope is passed into the duodenum and the papilla of Vater is cannulated. Radiopaque liquid contrast is injected into the biliary ducts, providing excellent contrast on x-ray images. Stones in bile appear as filling defects in the opacified ducts. Currently, ERCP is usually performed in conjunction with endoscopic retrograde sphincterotomy and gallstone extraction.
  • Endoscopic ultrasound (EUS) is also an accurate and relatively noninvasive technique to identify stones in the distal common bile duct.
  • Laparoscopic ultrasound has shown some promise as a primary method for bile duct imaging during laparoscopic cholecystectomy.4 Yao et al were able to evaluate the common bile duct with laparoscopic ultrasound during laparoscopic cholecystectomy in 112 of 115 patients (97.4%) with cholelithiasis. In patients who were categorized preoperatively as having a low probability of bile duct stones, the occurrence rate of stones was found to be 7%; in those who were preoperatively assessed as having an intermediate probability of such stones, the occurrence rate was 36.4%; and in those who were rated with the highest probability of bile duct stones, the occurrence rate was 78.9%.4

    The investigators suggested that as experience increases with laparoscopic ultrasound, this method may become routine for evaluating the bile duct during laparoscopic cholecystectomy. In addition, Yao et al advised mandatory aggressive preoperative evaluation of the common bile duct in those who are suspected to have an intermediate or high risk of having choledocholithiasis.4

More on Cholelithiasis

Overview: Cholelithiasis
Differential Diagnoses & Workup: Cholelithiasis
Treatment & Medication: Cholelithiasis
Follow-up: Cholelithiasis
Multimedia: Cholelithiasis
References
Further Reading

References

  1. Heuman DM, Moore EL, Vlahcevic ZR. Pathogenesis and dissolution of gallstones. In: Zakim D, Boyer TD, eds. Hepatology: A Textbook of Liver Disease. 1996. 3rd ed. Philadelphia, Pa: WB Saunders; 1996:376-417.

  2. Center SA. Diseases of the gallbladder and biliary tree. Vet Clin North Am Small Anim Pract. May 2009;39(3):543-98. [Medline].

  3. Wang HH, Liu M, Clegg DJ, Portincasa P, Wang DQ. New insights into the molecular mechanisms underlying effects of estrogen on cholesterol gallstone formation. Biochim Biophys Acta. Jul 6 2009;epub ahead of print. [Medline].

  4. Yao CC, Huang SM, Lin CC, et al. Assessment of common bile duct using laparoscopic ultrasound during laparoscopic cholecystectomy. Surg Laparosc Endosc Percutan Tech. Aug 2009;19(4):317-20. [Medline].

  5. Binenbaum SJ, Teixeira JA, Forrester GJ, et al. Single-incision laparoscopic cholecystectomy using a flexible endoscope. Arch Surg. Aug 2009;144(8):734-8. [Medline].

  6. Ghazal AH, Sorour MA, El-Riwini M, El-Bahrawy H. Single-step treatment of gall bladder and bile duct stones: A combined endoscopic-laparoscopic technique. Int J Surg. May 27 2009;epub ahead of print. [Medline].

  7. Behar J, Corazziari E, Guelrud M, et al. Functional gallbladder and sphincter of Oddi disorders. Gastroenterology. Apr 2006;130(5):1498-509. [Medline].

  8. Bhattacharya D, Ammori BJ. Contemporary minimally invasive approaches to the management of acute cholecystitis: a review and appraisal. Surg Laparosc Endosc Percutan Tech. Feb 2005;15(1):1-8. [Medline].

  9. Donovan JM. Physical and metabolic factors in gallstone pathogenesis. Gastroenterol Clin North Am. Mar 1999;28(1):75-97. [Medline].

  10. Ko CW, Beresford SA, Schulte SJ, Matsumoto AM, Lee SP. Incidence, natural history, and risk factors for biliary sludge and stones during pregnancy. Hepatology. Feb 2005;41(2):359-65. [Medline].

  11. Ko CW, Lee SP. Epidemiology and natural history of common bile duct stones and prediction of disease. Gastrointest Endosc. Dec 2002;56(6 suppl):S165-9. [Medline].

  12. Ko CW, Sekijima JH, Lee SP. Biliary sludge. Ann Intern Med. Feb 16 1999;130(4 p1):301-11. [Medline][Full Text].

  13. [Best Evidence] Mahid SS, Jafri NS, Brangers BC, et al. Meta-analysis of cholecystectomy in symptomatic patients with positive hepatobiliary iminodiacetic acid scan results without gallstones. Arch Surg. Feb 2009;144(2):180-7. [Medline].

  14. Martin DJ, Vernon DR, Toouli J. Surgical versus endoscopic treatment of bile duct stones. Cochrane Database Syst Rev. Apr 19 2006;CD003327. [Medline].

  15. [Guideline] NIH state-of-the-science statement on endoscopic retrograde cholangiopancreatography (ERCP) for diagnosis and therapy. NIH Consens State Sci Statements. Jan 14-16 2002;19(1):1-26. [Medline][Full Text].

  16. Portincasa P, Moschetta A, Palasciano G. Cholesterol gallstone disease. Lancet. Jul 15 2006;368(9531):230-9. [Medline].

  17. Ransohoff DF, Gracie WA. Treatment of gallstones. Ann Intern Med. Oct 1 1993;119(7 pt 1):606-19. [Medline][Full Text].

  18. Schwesinger WH, Diehl AK. Changing indications for laparoscopic cholecystectomy. Stones without symptoms and symptoms without stones. Surg Clin North Am. Jun 1996;76(3):493-504. [Medline].

  19. Shaffer EA. Epidemiology and risk factors for gallstone disease: has the paradigm changed in the 21st century?. Curr Gastroenterol Rep. May 2005;7(2):132-40. [Medline].

  20. Yusoff IF, Barkun JS, Barkun AN. Diagnosis and management of cholecystitis and cholangitis. Gastroenterol Clin North Am. Dec 2003;32(4):1145-68. [Medline].

Further Reading

Related eMedicine Topics

Clinical Trials

National Guideline Clearinghouse

Keywords

cholelithiasis, gallstones, gallstone disease, gallbladder stones, gallbladder disease, gallbladder pain, gall bladder removal, pure cholesterol gallstones, pure pigment gallstones, mixed gallstones, biliary sludge, biliary colic, cholecystectomy, common bile duct stones, gall stones, choledocholithiasis, cholecystolithiasis

Contributor Information and Disclosures

Author

Douglas M Heuman, MD, FACP, FACG, AGAF, Chief of Hepatology, Hunter Holmes McGuire Department of Veterans Affairs Medical Center; Professor, Department of Internal Medicine, Division of Gastroenterology, Virginia Commonwealth University School of Medicine
Douglas M Heuman, MD, FACP, FACG, AGAF is a member of the following medical societies: American Association for the Study of Liver Diseases, American College of Physicians, and American Gastroenterological Association
Disclosure: Nothing to disclose.

Coauthor(s)

Anastasios A Mihas, MD, DMSc, FACP, FACG, Professor, Department of Medicine, Division of Gastroenterology, Virginia Commonwealth University School of Medicine; Consulting Staff, Virginia Commonwealth University Hospitals and Clinics; Chief of GI Clinical Research, Director of GI Outpatient Service, Associate Director of Hepatology, Hunter Holmes McGuire Veterans Affairs Medical Center
Anastasios A Mihas, MD, DMSc, FACP, FACG is a member of the following medical societies: American Association for the Study of Liver Diseases, American College of Gastroenterology, American College of Physicians, American Federation for Clinical Research, American Gastroenterological Association, American Society for Gastrointestinal Endoscopy, Gastroenterology Research Group, Sigma Xi, and Southern Society for Clinical Investigation
Disclosure: Nothing to disclose.

Jeff Allen, MD, Assistant Professor, Department of Surgery, University of Louisville
Disclosure: Nothing to disclose.

Medical Editor

David Eric Bernstein, MD, Chief, Section of Hepatology, North Shore University Hospital, Director, Associate Professor, Department of Internal Medicine, Division of Hepatology, New York University School of Medicine
David Eric Bernstein, MD is a member of the following medical societies: American Association for the Study of Liver Diseases, American College of Gastroenterology, American College of Physicians, American Gastroenterological Association, and American Society for Gastrointestinal Endoscopy
Disclosure: Nothing to disclose.

Pharmacy Editor

Francisco Talavera, PharmD, PhD, Senior Pharmacy Editor, eMedicine
Disclosure: eMedicine Salary Employment

Managing Editor

BS Anand, MD, Professor, Department of Internal Medicine, Division of Gastroenterology, Baylor College of Medicine
BS Anand, MD is a member of the following medical societies: American Association for the Study of Liver Diseases, American College of Gastroenterology, American Gastroenterological Association, and American Society for Gastrointestinal Endoscopy
Disclosure: Nothing to disclose.

CME Editor

Alex J Mechaber, MD, FACP, Associate Dean for Undergraduate Medical Education, Associate Professor of Medicine, University of Miami Miller School of Medicine
Alex J Mechaber, MD, FACP is a member of the following medical societies: Alpha Omega Alpha, American College of Physicians-American Society of Internal Medicine, and Society of General Internal Medicine
Disclosure: Nothing to disclose.

Chief Editor

Julian Katz, MD, Clinical Professor of Medicine, Drexel University College of Medicine; Consulting Staff, Department of Medicine, Section of Gastroenterology and Hepatology, Hospital of the Medical College of Pennsylvania
Julian Katz, MD is a member of the following medical societies: American College of Gastroenterology, American College of Physicians, American Gastroenterological Association, American Geriatrics Society, American Medical Association, American Society for Gastrointestinal Endoscopy, American Society of Law Medicine and Ethics, American Trauma Society, Association of American Medical Colleges, and Physicians for Social Responsibility
Disclosure: Nothing to disclose.

 
 
HONcode

We subscribe to the
HONcode principles of the
Health On the Net Foundation

All material on this website is protected by copyright, Copyright© 1994- by Medscape.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.